Curbing Industry Sponsor's Incentive to Design Post-Approval Trials That Are Suboptimal for Informing Prescribers but More Likely than Optimal Designs to Yield Favorable Results

Authors

Benjamin P. Falit

Recommended Citation

Falit, Benjamin (2007) "Curbing Industry Sponsor's Incentive to Design Post-Approval Trials That Are Suboptimal for Informing Prescribers but More Likely than Optimal Designs to Yield Favorable Results," Seton Hall Law Review: Vol. 37 : Iss. 4 , Article 3.
Available at: https://scholarship.shu.edu/shlr/vol37/iss4/3